Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers
- PMID: 24676844
- DOI: 10.1007/s00198-014-2676-7
Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers
Abstract
This study examined whether markers of bone turnover differ between individuals with and without diabetes. Bone markers showed heterogeneity between studies and were discrepant for markers of bone creation and markers of bone degradation. Bone markers may be of lesser value in diabetes due to heterogeneity.
Introduction: The aim of this meta-analysis was to compare existing literature regarding changes in bone markers among diabetics compared to healthy controls. To exclude that blood glucose levels among diabetes patients could influence the assays used for determining bone turnover markers, a methodological study was performed.
Methods: Medline at Pubmed Embase, Cinahl, Svemed+, Cochrane library, and Bibliotek.dk was searched in August 2012. The studies should examine biochemical bone turnover among diabetes patients in comparison to controls in an observational design. In the methodological study, fasting blood samples were drawn from two individuals. Glucose was added to the blood samples in different concentrations and OC, CTX, and procollagen type 1 amino terminal propeptide were measured after 0, 1, 2, and 3 h.
Results: Twenty-two papers fulfilled the criteria for the meta-analysis. From the pooled data in the meta-analysis, the bone markers osteocalcin (OC) (-1.15 ng/ml [-1.78,-0.52]) and C-terminal cross-linked telopeptide (CTX) (-0.14 ng/ml [-0.22, -0.05]) were significantly lower among diabetes patients than non-diabetes patients, however other markers did not differ. All markers displayed very high heterogeneity by I2 statistics. In the methodological study, the addition of glucose did not significantly change the bone markers neither by level of glucose nor with increasing incubation time.
Conclusion: The dissociative pattern of biochemical bone markers of bone formation and bone resorption present in diabetes patients is thus not caused by glucose per se but may be modulated by unknown factors associated with diabetes mellitus.
Similar articles
-
Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus.J Diabetes Res. 2020 Aug 10;2020:6191468. doi: 10.1155/2020/6191468. eCollection 2020. J Diabetes Res. 2020. PMID: 32851096 Free PMC article.
-
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.Eur J Endocrinol. 2017 Mar;176(3):R137-R157. doi: 10.1530/EJE-16-0652. Eur J Endocrinol. 2017. PMID: 28049653 Review.
-
Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.Geriatr Gerontol Int. 2017 May;17(5):773-778. doi: 10.1111/ggi.12785. Epub 2016 May 2. Geriatr Gerontol Int. 2017. PMID: 27137883
-
Differences in biochemical bone markers by diabetes type and the impact of glucose.Bone. 2016 Feb;83:149-155. doi: 10.1016/j.bone.2015.11.004. Epub 2015 Nov 10. Bone. 2016. PMID: 26555635
-
Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.Bone. 2010 Aug;47(2):413-23. doi: 10.1016/j.bone.2010.05.001. Epub 2010 May 7. Bone. 2010. PMID: 20452475 Review.
Cited by
-
Osteocalcin associates with bone mineral density and VDR gene polymorphisms in type 1 and type 2 diabetes.Adv Lab Med. 2023 Oct 24;5(1):46-55. doi: 10.1515/almed-2023-0131. eCollection 2024 Mar. Adv Lab Med. 2023. PMID: 38634086 Free PMC article.
-
Estudio del efecto del tratamiento con fármacos antidiabéticos sobre el metabolismo óseo.Adv Lab Med. 2024 Mar 25;5(1):90-95. doi: 10.1515/almed-2024-0033. eCollection 2024 Mar. Adv Lab Med. 2024. PMID: 38634085 Free PMC article. Spanish.
-
La osteocalcina se asocia con la densidad mineral ósea y los polimorfismos del gen VDR en la diabetes tipo 1 y 2.Adv Lab Med. 2023 Dec 13;5(1):56-65. doi: 10.1515/almed-2023-0158. eCollection 2024 Mar. Adv Lab Med. 2023. PMID: 38634084 Free PMC article. Spanish.
-
Effects of antidiabetic drugs on bone metabolism.Adv Lab Med. 2024 Apr 3;5(1):85-89. doi: 10.1515/almed-2024-0038. eCollection 2024 Mar. Adv Lab Med. 2024. PMID: 38634079 Free PMC article.
-
Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes-Induced Bone Disease.JBMR Plus. 2023 Nov 17;7(12):e10843. doi: 10.1002/jbm4.10843. eCollection 2023 Dec. JBMR Plus. 2023. PMID: 38130754 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical